The weight-loss drug Zepbound is about to be considerably significantly less expensive for the decide on group of people that go ahead and take medication.Deep Dive Biotech’s M&A outlook is uncertain. Track the promotions which might be happening listed here. Billion-greenback biotech buyouts have become rarer. Only six on the acquisitions tracke